<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for SB 1412         </title>
<shortdesc>DHFS-GENERIC DRUG LABEL</shortdesc>
<sponsor>
<sponsorhead1>Senate Sponsors</sponsorhead1><sponsors>Sen. Laura M. Murphy</sponsors>
</sponsor>
<lastaction>
<statusdate>1/7/2025</statusdate><chamber>Senate</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>20 ILCS 2205/2205-40 new</reference><aliasreference></aliasreference><reference>20 ILCS 2205/2205-45 new</reference><aliasreference></aliasreference><SynopsisText>Amends the Department of Healthcare and Family Services Law of the Civil Administrative Code of Illinois. Provides that the Department of Healthcare and Family Services shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. Provides that the Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. Requires the Department to adopt rules to implement and administer the program. Establishes the State Generic Drug Label Task Force to study the cost savings of establishing a State prescription generic drug label. Contains provisions concerning membership on the Task Force; Task Force meetings; administrative support to the Task Force; reporting requirements; and other matters. Provides that the provisions creating the Task Force are repealed on January 1, 2025. Effective immediately.</SynopsisText></synopsis>
<actions>
<statusdate>2/6/2023</statusdate><chamber>Senate</chamber><action>Filed with Secretary by Sen. Laura M. Murphy</action>
<statusdate>2/6/2023</statusdate><chamber>Senate</chamber><action>First Reading</action>
<statusdate>2/6/2023</statusdate><chamber>Senate</chamber><action>Referred to Assignments</action>
<statusdate>2/14/2023</statusdate><chamber>Senate</chamber><action>Assigned to Executive</action>
<statusdate>2/23/2023</statusdate><chamber>Senate</chamber><action>To Subcommittee on Procurement</action>
<statusdate>3/1/2023</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Filed with Secretary by Sen. Laura M. Murphy</action>
<statusdate>3/1/2023</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Referred to Assignments</action>
<statusdate>3/7/2023</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Assignments Refers to Executive</action>
<statusdate>3/10/2023</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As March 24, 2023</action>
<statusdate>3/23/2023</statusdate><chamber>Senate</chamber><action>Rule 2-10 Committee Deadline Established As March 31, 2023</action>
<statusdate>3/31/2023</statusdate><chamber>Senate</chamber><action>Rule 3-9(a) / Re-referred to Assignments</action>
<statusdate>3/31/2023</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments</action>
<statusdate>1/7/2025</statusdate><chamber>Senate</chamber><action>Session Sine Die</action>
</actions>
</xml>

